Loading clinical trials...
Loading clinical trials...
This study investigates if a new imaging device can detect different types of lung tissue using spatial frequency domain imaging (SFDI). Specifically, this study aims to detect lung nodules within normal lung tissue and determine if lung nodules are cancerous. Patients who have confirmed or suspected lung nodules and who are undergoing resection of those nodules will be recruited for the study. Study participants will undergo standard of care lung nodule resection in the operating room, and the resected specimen will be imaged using the SFDI device immediately after removal from the surgical field. The data captured from the SFDI images will then be compared to the pathology findings to identify optical properties of normal and cancerous lung tissue. Because the intervention is conducted on resected biospecimens, this study yields minimal risk to participants.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California, Irvine Medical Center
Orange, California, United States
Start Date
August 7, 2023
Primary Completion Date
August 1, 2025
Completion Date
December 31, 2026
Last Updated
August 12, 2024
20
ESTIMATED participants
Spatial Frequency Domain Imaging
DEVICE
Lead Sponsor
University of California, Irvine
NCT04707781
NCT07300696
NCT07227376
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions